Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs



Rating:

Share or cite this content

Citations should be made in the following way:
P. Lepage (Jouy en Josas, France). Manipulating the microbiome to control human diseases. International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs

Member's Comments

No comment yet.

Related content which might interest you: Targeting the microbiome in respiratory diseases Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 Dynamics of the human microbiome network Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs Year: 2018 Development and homeostasis of a healthy microbiome in the human respiratory tract Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 The microbiome in chronic respiratory diseases Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice? Year: 2017 The microbiome and childhood respiratory diseases Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 Mechanistic insight into the function of the microbiome in lung diseases Source: Eur Respir J, 50 (3) 1602467; 10.1183/13993003.02467-2016 Year: 2017 Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism Source: Eur Respir J, 58 (1) 2003434; 10.1183/13993003.03434-2020 Year: 2021 How does the gut microbiota regulate immune responses in the airways? Source: Annual Congress 2006 - Can environmental exposures prevent allergic disease, what are the mechanisms and how important is timing of exposure? Year: 2006 Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing Source: Eur Respir J 2014; 44: 1682-1696 Year: 2014 Characterising the respiratory microbiome Source: Eur Respir J, 53 (2) 1801711; 10.1183/13993003.01711-2018 Year: 2019 Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 Microengineered systems to mimic human lung pathophysiology Source: International Congress 2017 – Innovative approaches to model human lung diseases Year: 2017 Microbiome effects on immunity, health and diseases of the lungs Source: Virtual Congress 2020 – Air pollution and interstitial lung disease: a call to arms Year: 2020 Impact of cellular composition on SARS-CoV-2 infection biology and pathogenesis in primary human airway epithelial cells Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 From culturomics to metagenomics: the mycobiome in chronic respiratory diseases Source: Eur Respir Monogr 2019; 83: 88-118 Year: 2019